Jia Jie Lim

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Reactive multi-target 'fragment drugs' represent critical components of current tuberculosis regimens. These compounds, such as pyrazinamide, are old synthetic antimycobacterials that are activated inside Mycobacterium tuberculosis bacilli and are smaller than the usual drug-like, single-target molecules. Based on the success of small 'dirty' drugs in the(More)
  • 1